CLINICAL_TRIALS
research
· 2017-02-03
Clinical Trial Update: Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal Cancer [Phase 3]
Summary
Phase 3 clinical trial assessing whether circulating tumor DNA can aid diagnosis, guide treatment decisions, and monitor recurrence in surgically resectable col…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: Rectal Cancer, Adenocarcinoma, Neoadjuvant Chemoradiation | Phase 3 | Status: UNKNOWN